Pulse nav.journalClub Aktive Debatten Trends Entdecken Forschende

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Start Entdecken nav.journalClub Trends

⌘+K

© Synapse Social LLC, 2026

May 20, 2013

Exenatide and the treatment of patients with Parkinson’s disease

Key Points

Key points are not available for this paper at this time.

Abstract

Cure Parkinson's Trust.

KI fragen

Like

Bookmark

Share

KI fragen

Like

Bookmark

Share

Cite This Study

Avilés-Olmos et al. (Mon,) studied this question.

synapsesocial.com/papers/69d56c2f75589c71d767cc78 https://doi.org/https://doi.org/10.1172/jci68295

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Rate of clinical progression in Parkinson's disease. A prospective study2007 · 169 citations
2Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.2005 · 133 citations
3Proof of principle studies2005 · 68 citations
4Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease2004 · 562 citations
5Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.1992 · 985 citations

Exenatid und die Behandlung von Patienten mit Parkinson-Krankheit | Synapse